EUCTR2009-010842-67-IT进行中（未招募）不适用
Effects of periprocedural atorvastatin therapy on patients undergoing percutaneous coronary intervention (PCI) - ATTICA
OSPEDALE G.PASQUINUCCI-FONDAZIONE TOSCANA GABRIELE MONASTERIO0 个研究点开始时间: 2009年3月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.presence of typical stable effort angina
- •2. positive stress test (either ECG, nuclear scan, or stress echocardiogram)
- •3.indication for coronary angioplast.
- •4.Provide written informed consent before randomization.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.acute myocardial infarction (< 3 months);
- •2.unstable angina;
- •3.any increase in CK-MB, troponin I, or myoglobin above upper normal limit at the time of randomization;
- •4.any increase in liver enzymes (AST/ALT);
- •5.left ventricular ejection fraction <30%
- •6.renal failure with creatinine >3 mg/dL;
- •7.history of liver or muscle disease;
- •8.Systemic autoimmune and inflammatory diseases
- •9.Participation in any phase of another clinical research study involving the evaluation of another investigational drug or device within 30 days prior to randomization
- •10.Inability to give at least verbal informed consent to the study.
- •11.Counter indications foreseen in medical information pamphlet
研究者
相似试验
招募中
3 期
The effect of atorvastatin in the prevention of gastrointestinal toxicity in patients undergoing pelvic radiotherapyIRCT20200825048515N36Esfahan University of Medical Sciences64
招募中
不适用
Evaluation of the effect of Atorvastatin in diabetic type 2 patients in the morning and eveningIRCT20211211053359N1Babol University of Medical Sciences76
招募中
3 期
The effect of atorvastatin administration on the outcome of patients with traumatic brain injuryIRCT20210113050023N1Ahvaz University of Medical Sciences60
进行中（未招募）
1 期
Reduction of prostate cancer growth with cholesterol-lowering atorvastatin drugMedDRA version: 14.1 Level: PT Classification code 10060862 Term: Prostate cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate cancerEUCTR2011-005438-20-FIniversity of Tampere160
已完成
3 期
Effect of Atorvastatin in Helicobacter pylori eradicatioHelicobacter pylori infection.IRCT20190823044589N1Oroumia University of Medical Sciences120